parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Modelling Parkinson's Disease: iPSCs towards
Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect Decoding Parkinson's Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations PMC Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing ScienceDirect
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




